GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ADR120S Inc (TSE:3750) » Definitions » Institutional Ownership

ADR120S (TSE:3750) Institutional Ownership : 0.19% (As of Jul. 10, 2025)


View and export this data going back to 2004. Start your Free Trial

What is ADR120S Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ADR120S's institutional ownership is 0.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ADR120S's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ADR120S's Float Percentage Of Total Shares Outstanding is 0.00%.

ADR120S Institutional Ownership Historical Data

The historical data trend for ADR120S's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ADR120S Institutional Ownership Chart

ADR120S Historical Data

The historical data trend for ADR120S can be seen below:

2015-06-30 2015-07-31 2015-08-31 2015-09-30 2015-10-31 2015-11-30 2015-12-31 2016-01-31 2016-02-29 2016-03-31
Institutional Ownership 6.47 6.47 6.47 6.47 0.96 0.19 0.19 0.19 0.19 0.19

ADR120S Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

ADR120S Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ADR120S Inc (TSE:3750) » Definitions » Institutional Ownership
Comparable Companies
TSE:4891 TSE:4893 TSE:4564 TSE:2183 TSE:4572 TSE:4598 TSE:4884 TSE:4896 TSE:4576 TSE:177A VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Website
https://www.cytori.co.jp
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

ADR120S Headlines

No Headlines